Beyond the hemostatic factors, we meticulously explored the potential confounders, including biomarkers associated with CRC or other cancers identified in prior studies (e.g., UA, AST, ALT, GLU, HDL, and PLT) [32–36]. The gene discussed is GPT; the disease is colorectal carcinoma.